Newsfeed
June 26, 2013
The draft RSPV Regulations provide for the authorisation and regulation of SPRVs in Malta, being special purpose vehicles that assume risks from a ceding insurance / reinsurance undertaking and which fully fund their exposure by means of a debt issue or other financing mechanism.
SPRVs (or ISPVs as the entities are known in some jurisdictions) are central to a wide variety of alternative risk transfer structures that bridge the insurance industry with the capital markets including catastrophe bonds, longevity risk securitisation and sidecars. RSPVs may also be useful as alternative capital sources for Lloyd’s syndicates.
The publication of the draft RSPV Regulations was followed by a two-week consultation process that ended on the 17th June 2013. We understand that the MFSA is now in the process of digesting all feedback received during the consultation period and will be publishing its feedback shortly.
The draft RSPV Regulations define a Reinsurance Special Purpose Vehicle as an undertaking other than an existing insurance undertaking or reinsurance undertaking which assumes risks from a ceding undertaking and which fully funds its exposure to such risks through the proceeds of a debt issuance or any other financing mechanism where the repayment right of the providers of such debt or financing mechanism is subordinated to the reinsurance obligations of such a vehicle. SPRVs are expressly recognised by the EU Reinsurance Directive (2005/68/EC) and Solvency II Directive (2009/138/EC).
Limited liability companies formed or constituted in Malta whose objects are limited to operating as an SPRV may apply for authorisation.
RSPVs within the scope of the draft Regulations are required to obtain MFSA authorisation prior to entering into any transaction.
Reinsurance Special Purpose Vehicles may be used in catastrophe bond, sidecar, collateralised reinsurance and transformer structures.
In terms of the draft RSPV Regulations, an applicant wishing to obtain an SPRV authorisation in Malta is to:
The authorisation process commences with the submission of a scheme of operations outlining the proposed structure and acticvities of the vehicles. Additional documentation is to be submitted in conjunction with the scheme of operations including:
In terms of the draft RSPV Regulations, an SPRV is required to have a system of governance including:
Yes. The governance arrangements of an SPRV are to be drawn up taking into account the nature scale and complexity of the proposed of the risks that the SPRV will assume and the uses of the SPRV.
An SPRV is to be fully funded at all times to the maximum aggregate exposure under the risk transfer contract. In this regard, claims of debtholders and investors providing financing to the SPRV are to be subordinated to the claims of the ceding undertaking in terms of the risk transfer contract.
The assets of an SPRV are to be valued in accordance with generally accepted accounting principles and practice. The proceeds of the debt issuance by the SPRV are to be fully paid-up.
The proceeds of any debt raised by the SPRV to finance its contingent liability under the risk transfer contract are to be invested in accordance with the prudent person principle. The draft SPRV Regulations require authorised vehicles to sufficiently diversify investments taking into account the nature and duration of the vehicles’ contingent liabilities. Assets are to be invested in a manner as to ensure the security, quality, liquidity and profitability of the portfolio as a whole.
It is anticipated that the RSPV Regulations will become law during the second half of 2013.
Malta is a European Union domicile with an established reputation in the captive insurance and protected cell company market. As of 31 December, 2012, 58 insurance undertakings operated from Malta, including 8 protected cell companies (PCCs).
Once these regulations come into force, Malta’s offering as a domicile for ART transactions will be significantly enhanced.
For more information or if you have any questions, please feel free to contact the author (Dr. Matthew Mizzi (Advocate, Insurance Securitisation)) or Dr. Matthew Bianchi (Partner, Insurance & Reinsurance) or Mr. Richard Ambery (Partner, Capital Markets).